adrenoceptor blockers Flashcards

1
Q

 All active by
 Oral route
 Parenteral route

A

alpha blocking drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

IRREVERSIBLE LONG-ACTING

	Prototype
	Only slightly alpha1 selective
	Short elimination half life
	Long duration of action (48 hours)
	Binds covalently to the alpha receptors
A

PHENOXYBENZAMINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

DoA of PHENOXYBENZAMINE

A

48 hours)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

REVERSIBLE SHORT-ACTING

•	Prototype
•	Nonselective (alpha1=alpha2)
	Duration of action
	Oral (2-4 hours)
	IV (20-40 minutes)
A

PHENTOLAMINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

ALPHA1 SELECTIVE

 Prototype
 Selective reversible alpha1 blocker
 Duration of action 8-24 hours
 Doxasozin, terazosin and tamsulosin

A

PRAZOSIN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q
  • Prototype
  • Selective alpha2 competitive blockers
  • Used primarily in research application
A

YOHIMBINE, RAUWOLSCINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

NONSELECTIVE BLOCKERS

 Most important effects are on the ??

A

CVS system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

 Predictable result of the use of an agonist in a patient who has received
an alpha-blocker
 Reversal in the BP effect of large doses of epinephrine
 From pressor response (alpha receptors) to a depressor response (beta receptors)
 Not observed with phenylephrine or NE because they lack sufficient beta2 effects

A

EPINEPHRINE REVERSAL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

 Block alpha1 receptors much more effectively

 Cause much less tachycardia than the nonselective blockers when reducing BP

A

SELECTIVE ALPHA1 BLOCKERS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

• Tumor that secretes cathecolamines

A

pheochromocytoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

type of BLOCKERS

• Severe hypertension caused by overdose with drugs of abuse such as amphetamine, cocaine, or phenylpropanolamine

A

NONSELECTIVE ALPHA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

type of BLOCKERS
 Prazosin, doxazosin, and terazosin are used in hypertension
 Used together with tamsulosin for urinary hesitancy and prevention of urinary retention with benign prostatic hyperplasia

A

SELECTIVE ALPHA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Prazosin, doxazosin, and terazosin Used together with ? for urinary hesitancy and prevention of urinary retention with benign prostatic hyperplasia

A

tamsulosin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

• TOXICITY of alpha blockers

A

Main manifestation is orthostatic hypotension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

 Competitive pharmacologic antagonists
 Propranolol is the prototype
 Developed for chronic oral use
• Bioavailability and duration of action vary widely

A

BETA BLOCKING DRUGS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Beta1 receptor selectivity

A

Acebutolol
Atenolol
Esmolol
Metoprolol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Advantage when treating patients with asthma

A

Beta1 receptor selectivity

PARTIAL AGONIST ACTIVITY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Nonselective beta-blockers

A

 Nadolol
 Propranolol
 Timolol
 Pindolol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

 Combined alpha and beta-blockers
 Optically active

A

Labetalol

 Carvedilol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

PARTIAL AGONIST ACTIVITY
 ”Intrinsic sympathomimetic activity”

 May be an advantage in treating patients with asthma
 At maximum dose, can cause some bronchodilatation

A

Pindolol
 Acebutolol
 Labetalol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

 ”Membrane stabilizing ability”
 Disadvantage when a beta-blocker is used topically in the eye because it decreases protective reflexes and increases the risk of corneal ulceration

A

LOCAL ANESTHETIC ACTIVITY

22
Q

LOCAL ANESTHETIC ACTIVITY

A
	Acebutolol
	Labetalol
	Metoprolol
	Propranolol 	
	Pindolol
23
Q
  • Short-acting ester

* Used only parenterally

24
Q
  1. Longest acting beta-blocker
25
 Less lipid soluble |  Enter the CNS to a lesser extent
ACEBUTOLOL, ATENOLOL and NADOLOL
26
 EFFECTS of beta blockers in CVS
 Decrease BP  Antagonize renin secretion  (-) inotropic effect  (-) chronotropic effect
27
 EFFECTS of beta blockers in RESPIRATORY
Bronchoconstriction | Increase airway resistance
28
EFFECTS of beta blockers in EYE
* Decrease intraocular pressure | * Decrease production of aqueous humor
29
EFFECTS of beta blockers inMETABOLIC AND ENDOCRINE
* Reduce insulin secretion | * Caution for insulin dependent DM
30
 CLINICAL USES of beta blockers
```  Open-angle glaucoma  Hypertension  Angina • Arrhythmias • Chronic heart failure • Pheochromocytoma ```
31
TOXICITY in CVS
1. CVS 1. Bradycardia 2. AV blockade 3. Heart failure
32
TOXICITY in RESPIRATORY
1. Worsen the asthma
33
TOXICITY in CNS
1. Sedation 2. Fatigue 3. Sleep alteration 4. Depression 5. Psychosis
34
TOXICITY in CNS
1. Sedation 2. Fatigue 3. Sleep alteration 4. Depression 5. Psychosis
35
Conversion of the pressor response to epinephrine (typical of large doses) to a blood pressure–lowering effect; caused by α blockers, which unmask the β2 effects of epinephrine
Epinephrine reversal
36
Partial agonist action by adrenoceptor blockers; typical of several β blockers (eg, pindolol, acebutolol)
Intrinsic sympathomimetic | activity (ISA)
37
Local anesthetic action; typical of several β blockers (eg, propranolol)
Membrane-stabilizing | activity (MSA)
38
Hypotension that is most marked in the upright position; caused by venous pooling (typical of α blockade) or inadequate blood volume (caused by blood loss or excessive diuresis)
Orthostatic hypotension
39
A tumor consisting of cells that release varying amounts of norepinephrine and epinephrine into the circulation
Pheochromocytoma
40
Drugs used in glaucoma. | Beta blockers
Timolol, others
41
Drugs used in glaucoma | Prostaglandins
Latanoprost, others
42
Drugs used in glaucoma. | Cholinomimetics
Pilocarpine, physostigmine
43
Drugs used in glaucoma. Alpha agonists Nonselective:
epinephrine
44
Drugs used in glaucoma. | Alpha2-selective agonists
Apraclonidine, brimonidine
45
Drugs used in glaucoma. | Carbonic anhydrase inhibitors
Acetazolamide, dorzolamide
46
Drugs used in glaucoma. | Osmotic agents
Mannitol
47
Clinical Applications | Pheochromocytoma, antidote to overdoseof α agonists
Phentolamine
48
Clinical Applications Pheochromocytoma, carcinoid, mastocytosis, Raynaud’s phenomenon
phenoxybenzamine
49
Clinical Applications Hypertension, benign prostatic hyperplasia
PRAZOSIN
50
Clinical Applications Obsolete use for erectile dysfunction • research use
YOHIMBINE
51
``` Clinical Applications Angina, arrhythmias (treatment and prophylaxis), hypertension, thyrotoxicosis, tremor, stage fright, migraine ```
PROPRANOLOL